Knoll Capital Management, LLC Diversified Active

Location: Miami, FL

CIK: 0001325083 · Show all filings

Period: Q1 2020 (← Previous) (Next →)

Filing Date: May 15, 2020

Total Value: $106M (100.0% shares, 0.0% debt)

Holdings (18)

— Biohaven Pharmactl Hldg Co L 27.4%

Value $29.18M Shares 857,494 Est. Cost $27.10 Unrealized —

— Corbus Pharmaceuticals HLDGS 24.8%

Value $26.44M Shares 5,045,870 Est. Cost $4.99 Unrealized —

— Applied Therapeutics Inc 19.7%

Value $20.99M Shares 642,071 Est. Cost $14.90 Unrealized —

— Abeona Therapeutics Inc 5.6%

Value $6.006M Shares 2,859,767 Est. Cost $4.67 Unrealized —

— Blackstone Group LP 3.4%

Value $3.646M Shares 80,000 Est. Cost $34.97 Unrealized —

ENTX Entera Bio Ltd 3.1%

Value $3.274M Shares 1,741,363 Est. Cost $3.39 Unrealized -18.6%

— Eiger Biopharmaceuticals Inc 3.0%

Value $3.232M Shares 475,238 Est. Cost $9.48 Unrealized —

AVXL Anavex Life Sciences Corp 2.1%

Value $2.281M Shares 724,205 Est. Cost $3.56 Unrealized -2.2%

— Centurylink Inc 2.0%

Value $2.081M Shares 220,000 Est. Cost $12.48 Unrealized —

— Exicure Inc 1.8%

Value $1.891M Shares 1,277,777 Est. Cost $2.86 Unrealized —

— Molecular Templates 1.4%

Value $1.514M Shares 113,905 Est. Cost $4.04 Unrealized —

ALDX Aldeyra Therapeutics Inc 1.3%

Value $1.406M Shares 569,405 Est. Cost $8.37 Unrealized -46.3%

— Soligenix Inc. 1.2%

Value $1.324M Shares 787,830 Est. Cost $2.11 Unrealized —

DOW Dow Inc 0.8%

Value $877K Shares 30,000 Est. Cost $36.37 Unrealized -15.9%

CTVA Corteva Inc 0.7%

Value $705K Shares 30,000 Est. Cost $25.02 Unrealized +2.2%

— Catasys Inc 0.6%

Value $655K Shares 43,034 Est. Cost $16.93 Unrealized —

DD Dupont de Nemours Inc 0.5%

Value $512K Shares 15,000 Est. Cost $27.24 Unrealized -33.4%

— BioXCel Therapeutics Inc 0.4%

Value $447K Shares 20,000 Est. Cost $22.35 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	Biohaven Pharmactl Hldg Co L	857,494	$29.18M	27.4%	$27.10	—	COM	G11196105
—	Corbus Pharmaceuticals HLDGS	5,045,870	$26.44M	24.8%	$4.99	—	COM	21833P103
—	Applied Therapeutics Inc	642,071	$20.99M	19.7%	$14.90	—	COM	03828A101
—	Abeona Therapeutics Inc	2,859,767	$6.006M	5.6%	$4.67	—	COM	00289Y107
—	Blackstone Group LP	80,000	$3.646M	3.4%	$34.97	—	COM UNIT LTD	09253U108
ENTX	Entera Bio Ltd	1,741,363	$3.274M	3.1%	$3.39	-18.6%	SHS	M40527109
—	Eiger Biopharmaceuticals Inc	475,238	$3.232M	3.0%	$9.48	—	COM	28249U105
AVXL	Anavex Life Sciences Corp	724,205	$2.281M	2.1%	$3.56	-2.2%	COM NEW	032797300
—	Centurylink Inc	220,000	$2.081M	2.0%	$12.48	—	COM	156700106
—	Exicure Inc	1,277,777	$1.891M	1.8%	$2.86	—	COM	30205M101
—	Molecular Templates	113,905	$1.514M	1.4%	$4.04	—	COM	608550109
ALDX	Aldeyra Therapeutics Inc	569,405	$1.406M	1.3%	$8.37	-46.3%	COM	01438T106
—	Soligenix Inc.	787,830	$1.324M	1.2%	$2.11	—	COM	834223307
DOW	Dow Inc	30,000	$877K	0.8%	$36.37	-15.9%	COM	260557103
CTVA	Corteva Inc	30,000	$705K	0.7%	$25.02	+2.2%	COM	22052L104
—	Catasys Inc	43,034	$655K	0.6%	$16.93	—	COM PAR	149049504
DD	Dupont de Nemours Inc	15,000	$512K	0.5%	$27.24	-33.4%	COM	26614N102
—	BioXCel Therapeutics Inc	20,000	$447K	0.4%	$22.35	—	COM	09075P105